High Tower Advisors, LLC Invitae Corp Transaction History

High Tower Advisors, LLC

$61.2 Billion
Q1 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.42 - $0.72 $14,718 - $25,231	-35,044 Reduced 5.84%	565,310 $356,000
Q3 2023 Nov 08, 2023	BUY	$0.6 - $1.53 $44,643 - $113,839	74,405 Added 14.15%	600,354 $360,000
Q2 2023 Aug 14, 2023	BUY	$1.05 - $1.63 $16,300 - $25,304	15,524 Added 3.04%	525,949 $594,000
Q1 2023 May 11, 2023	BUY	$1.2 - $2.73 $129,037 - $293,559	107,531 Added 26.69%	510,425 $689,000
Q4 2022 Feb 08, 2023	SELL	$1.71 - $3.61 $467,567 - $987,085	-273,431 Reduced 40.43%	402,894 $749,000

Q3 2022 Nov 09, 2022	SELL	$1.9 - $8.63 $252,078 - $1.14 Million	-132,673 Reduced 16.4%	676,325 $1.64 Million
Q2 2022 Aug 10, 2022	SELL	$2.13 - $9.01 $427,789 - $1.81 Million	-200,840 Reduced 19.89%	808,998 $1.95 Million
Q1 2022 May 12, 2022	BUY	$6.28 - $15.59 $2.12 Million - $5.27 Million	338,149 Added 50.34%	1,009,838 $8.04 Million
Q4 2021 Feb 10, 2022	BUY	$14.7 - $28.67 $3.39 Million - $6.61 Million	230,534 Added 52.26%	671,689 $10.3 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $892,638 - $1.23 Million	36,719 Added 9.08%	441,155 $12.5 Million
Q2 2021 Aug 06, 2021	BUY	$26.09 - $40.4 $2.05 Million - $3.17 Million	78,430 Added 24.06%	404,436 $13.6 Million
Q1 2021 May 10, 2021	BUY	$33.06 - $56.93 $983,601 - $1.69 Million	29,752 Added 10.04%	326,006 $12.4 Million
Q4 2020 Feb 10, 2021	SELL	$39.09 - $57.4 $399,656 - $586,857	-10,224 Reduced 3.34%	296,254 $12.4 Million
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $45,516 - $71,516	1,601 Added 0.53%	306,478 $13.3 Million
Q2 2020 Aug 10, 2020	BUY	$11.71 - $30.29 $13,197 - $34,136	1,127 Added 0.37%	304,877 $9.23 Million
Q1 2020 May 21, 2020	BUY	$7.64 - $27.5 $99,824 - $359,315	13,066 Added 4.49%	303,750 $4.15 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $292,214 - $400,189	-19,455 Reduced 6.27%	290,684 $4.68 Million
Q3 2019 Nov 12, 2019	SELL	$18.85 - $27.5 $491,400 - $716,897	-26,069 Reduced 7.75%	310,139 $5.97 Million
Q2 2019 Aug 13, 2019	SELL	$17.37 - $26.27 $326,364 - $493,587	-18,789 Reduced 5.29%	336,208 $7.9 Million
Q1 2019 May 15, 2019	SELL	$10.65 - $25.75 $76,988 - $186,146	-7,229 Reduced 2.0%	354,997 $8.3 Million
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $1.43 Million - $2.53 Million	-154,430 Reduced 29.89%	362,226 $4 Million
Q3 2018 Nov 09, 2018	SELL	$7.54 - $18.31 $115,045 - $279,373	-15,258 Reduced 2.87%	516,656 $8.65 Million
Q2 2018 Aug 14, 2018	BUY	$4.87 - $8.42 $807,864 - $1.4 Million	165,886 Added 45.32%	531,914 $3.91 Million
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $211,669 - $453,576	45,132 Added 14.06%	366,028 $1.72 Million
Q4 2017 Feb 14, 2018	BUY	$7.86 - $9.99 $234,479 - $298,021	29,832 Added 10.25%	320,896 $2.91 Million
Q3 2017 Nov 14, 2017	BUY	$8.89 - $10.4 $230,864 - $270,077	25,969 Added 9.8%	291,064 $2.73 Million
Q2 2017 Aug 14, 2017	BUY	N/A	265,095	265,095 $2.54 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account